Publicaciones en colaboración con investigadores/as de Hospital de Fuenlabrada (10)

2023

  1. Baricitinib or imatinib in hospitalized COVID-19 patients: Results from COVINIB, an exploratory randomized clinical trial

    Journal of Medical Virology, Vol. 95, Núm. 2

2022

  1. Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients

    Journal of Infection

2021

  1. COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors

    Cancer

  2. Imatinib in COVID-19: hope and caution

    The Lancet Respiratory Medicine

2017

  1. Evolocumab in patients with cardiovascular disease

    New England Journal of Medicine

  2. Novel risk factors related to cancer in scleroderma

    Autoimmunity Reviews, Vol. 16, Núm. 5, pp. 461-468

  3. Understanding the Role of Antibodies as Markers of Cancer-Associated Systemic Sclerosis: Comment on the Article by Shah et al

    Arthritis and Rheumatology

2014

  1. De medicina de una universidad española

    Revista Clinica Espanola, Vol. 214, Núm. 7, pp. 371-376

  2. Vitamin D status and ill health

    The Lancet Diabetes and Endocrinology

2012

  1. Effectiveness of a diagnostic algorithm combining clinical probability, D-dimer testing, and computed tomography in patients with suspected pulmonary embolism in an emergency department.

    Romanian journal of internal medicine = Revue roumaine de médecine interne, Vol. 50, Núm. 3, pp. 195-202